|
KMID : 1137020190300020031
|
|
Journal of Gynecologic Oncology
2019 Volume.30 No. 2 p.31 ~ p.31
|
|
|
Clinical guideline for 9-valent HPV vaccine: Korean Society of Gynecologic Oncology Guideline
|
|
Min Kyung-Jin
Kwon Sang-Hoon
Kim Ki-Dong
Kim Sung-Hoon
Kim Hyun-Jung
Seong Seok-Ju
Song Yong-Jung
Lee Keun-Ho
Lee Shin-Wha
Lee Jeong-Won
Chang Suk-Joon
Ju Woong
Kim Young-Tak
Lee Jae-Kwan
|
|
|
Abstract
|
|
|
|
In 2016, 9-valent human papillomavirus (HPV) vaccine has been newly introduced in Korea, thus the need to develop recommendations for the vaccine has raised. Until we decide to develop a guideline, no further studies on the bi-valent or quadri-valent HPV vaccine have been announced. We searched and reviewed the literatures focused on the efficacy of 9-valent HPV vaccine, the ideal age of 3-dose schedule vaccination, the efficacy of 9-valent HPV vaccine in middle-aged women, the efficacy of the 2-dose schedule vaccination, the safety of 9-valent HPV vaccine, the possibility of additional 9-valent HPV vaccination, and cross-vaccination of 9-valent HPV vaccine. So, Korean Society of Gynecologic Oncology (KSGO) developed a guideline only for 9-valent HPV vaccine.
|
|
|
KEYWORD
|
|
|
Papillomavirus Vaccines, Practice Guidelines, Female, Male
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
    
|